tiprankstipranks
Advertisement
Advertisement

HK:2592 Stock Latest News

Cloudbreak Pharma Sets Board Meeting to Review Interim Results and Dividend
Company AnnouncementsCloudbreak Pharma Sets Board Meeting to Review Interim Results and Dividend
10d ago
2592
Cloudbreak Pharma Wins FDA Safety Clearance to Begin CBT-358 Clinical Investigation
PremiumCompany Announcements
Cloudbreak Pharma Wins FDA Safety Clearance to Begin CBT-358 Clinical Investigation
1M ago
2592
Cloudbreak Pharma strengthens governance with new company secretary
PremiumCompany Announcements
Cloudbreak Pharma strengthens governance with new company secretary
1M ago
2592
Cloudbreak Pharma Wins Near-Unanimous Shareholder Support at 2026 AGM
PremiumCompany Announcements
Cloudbreak Pharma Wins Near-Unanimous Shareholder Support at 2026 AGM
2M ago
2592
Cloudbreak Pharma sets up US$15 million flexible share subscription facility
PremiumCompany Announcements
Cloudbreak Pharma sets up US$15 million flexible share subscription facility
2M ago
2592
Cloudbreak Reaches Key Phase 3 Milestone for First-in-Class Pterygium Drug CBT-001
PremiumCompany AnnouncementsCloudbreak Reaches Key Phase 3 Milestone for First-in-Class Pterygium Drug CBT-001
3M ago
2592
Cloudbreak Pharma Redirects IPO Proceeds to Broaden R&D Pipeline
Premium
Company Announcements
Cloudbreak Pharma Redirects IPO Proceeds to Broaden R&D Pipeline
3M ago
2592
Cloudbreak Pharma Sets 2026 AGM to Approve Accounts and Renew Share Issuance Mandate
Premium
Company Announcements
Cloudbreak Pharma Sets 2026 AGM to Approve Accounts and Renew Share Issuance Mandate
3M ago
2592
Cloudbreak Pharma Files U.S. IND for Novel Dry Eye Drug CBT-358
PremiumCompany Announcements
Cloudbreak Pharma Files U.S. IND for Novel Dry Eye Drug CBT-358
3M ago
2592
Cloudbreak Pharma delays annual meeting to late June
PremiumCompany Announcements
Cloudbreak Pharma delays annual meeting to late June
3M ago
2592
Cloudbreak Pharma Wins FDA Safety Nod to Advance Presbyopia Drug CBT-199
PremiumCompany Announcements
Cloudbreak Pharma Wins FDA Safety Nod to Advance Presbyopia Drug CBT-199
4M ago
2592
Cloudbreak Pharma Fully Redeems Fund, Clarifies Independence After Use-of-Proceeds Deviation
PremiumCompany Announcements
Cloudbreak Pharma Fully Redeems Fund, Clarifies Independence After Use-of-Proceeds Deviation
4M ago
2592
Cloudbreak Pharma to Redeem HK$47.1 Million Fund Investment After Use‑of‑Proceeds Deviation
PremiumCompany AnnouncementsCloudbreak Pharma to Redeem HK$47.1 Million Fund Investment After Use‑of‑Proceeds Deviation
5M ago
2592
Cloudbreak Pharma Narrows Annual Loss Despite Higher R&D Spending
Premium
Company Announcements
Cloudbreak Pharma Narrows Annual Loss Despite Higher R&D Spending
5M ago
2592
Cloudbreak Pharma Withdraws China IND for CBT-009, Refocuses Ophthalmic Pipeline Strategy
Premium
Company Announcements
Cloudbreak Pharma Withdraws China IND for CBT-009, Refocuses Ophthalmic Pipeline Strategy
5M ago
2592
Cloudbreak Pharma Sets March 30 Board Meeting to Approve 2025 Annual Results
PremiumCompany Announcements
Cloudbreak Pharma Sets March 30 Board Meeting to Approve 2025 Annual Results
5M ago
2592
Cloudbreak Pharma Wins FDA Green Light to Advance Presbyopia Drug CBT-199 Into Phase 2
PremiumCompany Announcements
Cloudbreak Pharma Wins FDA Green Light to Advance Presbyopia Drug CBT-199 Into Phase 2
6M ago
2592
Cloudbreak Pharma Lifts Asset Freeze as Legal Dispute with Cedar Wealth Fully Settled
PremiumCompany Announcements
Cloudbreak Pharma Lifts Asset Freeze as Legal Dispute with Cedar Wealth Fully Settled
7M ago
2592
Cloudbreak Pharma Secures Withdrawal of Arbitration in Cedar Wealth Dispute
PremiumCompany Announcements
Cloudbreak Pharma Secures Withdrawal of Arbitration in Cedar Wealth Dispute
7M ago
2592
Cloudbreak Pharma Ties Consultant RSU Grant to US$100 Million in Business Development Deals
PremiumCompany AnnouncementsCloudbreak Pharma Ties Consultant RSU Grant to US$100 Million in Business Development Deals
7M ago
2592
Cloudbreak Pharma Grants 8 Million RSUs Under Post-IPO Incentive Scheme
Premium
Company Announcements
Cloudbreak Pharma Grants 8 Million RSUs Under Post-IPO Incentive Scheme
7M ago
2592
Cloudbreak Pharma Settles Dispute With Cedar Wealth for USD2.22 Million
Premium
Company Announcements
Cloudbreak Pharma Settles Dispute With Cedar Wealth for USD2.22 Million
8M ago
2592

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >